MedPath
HSA Approval

ORATANE CAPSULE 20 mg

SIN11781P

ORATANE CAPSULE 20 mg

ORATANE CAPSULE 20 mg

January 23, 2002

APEX PHARMA MARKETING PTE. LTD.

APEX PHARMA MARKETING PTE. LTD.

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantAPEX PHARMA MARKETING PTE. LTD.
Licence HolderAPEX PHARMA MARKETING PTE. LTD.

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
Prescription Only
HSA Singapore Classification

Formulation Information

CAPSULE

ORAL

Medical Information

D10BA01

isotretinoin

Manufacturer Information

APEX PHARMA MARKETING PTE. LTD.

Douglas Manufacturing Ltd

Swiss Caps AG

Active Ingredients

ISOTRETINOIN

20.00mg

Isotretinoin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ORATANE CAPSULE 20 mg - HSA Approval | MedPath